Clinical trials
Hepatitis B, Chronic trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
57 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 2 |
| 2005 | 4 |
| 2007 | 2 |
| 2009 | 3 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 5 |
| 2019 | 4 |
| 2020 | 8 |
| 2021 | 5 |
| 2022 | 5 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 40 |
| Terminated | 9 |
| Active, not recruiting | 3 |
| Recruiting | 2 |
| Withdrawn | 2 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gilead Sciences | 9 |
| GlaxoSmithKline | 8 |
| Hoffmann-La Roche | 6 |
| Assembly Biosciences | 5 |
| Novartis Pharmaceuticals | 4 |
| Aligos Therapeutics | 3 |
| Janssen Research & Development, LLC | 3 |
| Janssen Sciences Ireland UC | 3 |
| Vir Biotechnology, Inc. | 3 |
| Bristol-Myers Squibb | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hepatitis B, Chronic | 57 |
| Hepatitis B | 23 |
| Hepatitis | 9 |
| Hepatitis, Chronic | 5 |
| Liver Diseases | 3 |
| DNA Virus Infections | 2 |
| Digestive System Diseases | 2 |
| Hepatitis, Viral, Human | 2 |
| Virus Diseases | 2 |
| Blood-Borne Infections | 1 |
Trials
Showing 1 to 25 of 57. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.